Biotech Growth Trust In Mixed Performance Against Benchmark

LONDON (Alliance News) - The Biotech Growth Trust PLC Thursday said its net asset value per share rose by 5.4%, compared with a rise of 6.1% in its benchmark, the NASDAQ Biotechnology Index, measured in sterling terms, over the three months to the end of June.

The company's share price rose by 5.9%, and ended the period on a 6.0% discount to its NAV.

From the end of June to August 5, the company's NAV fell by 0.1% and its share price fell by 1.7%. The benchmark experienced a fall of 0.7% over the same period.

By Samuel Agini; samagini@alliancenews.com; @samuelagini

Copyright 2014 Alliance News Limited. All Rights Reserved.

Biotech Gwth